Bayer Schering Pharma to build Euro 100m global r&d centre in China
Bayer Schering Pharma plans to strengthen its global r&d capabilities through the foundation of a global r&d centre in Beijing, China. The company will invest some Euro 100m over the next five years to establish the centre.
Bayer Schering Pharma plans to strengthen its global r&d capabilities through the foundation of a global r&d centre in Beijing, China. The company will invest some Euro 100m over the next five years to establish the centre.
"We are continuously increasing our presence in the Asia Pacific Region where China is our key growth driver," said Andreas Fibig, executive committee member of Bayer HealthCare and chairman of Bayer Schering Pharma's board of management.
"In our new r&d centre in Beijing, we will establish a world class team extending our global r&d expertise and capabilities. Beijing will be an important site for our global innovative drug development."
China is the third largest market worldwide for the Bayer group, and it will become the third country besides Germany and the US to host a global r&d centre for Bayer Schering Pharma.
"Our goal is to build a world class organisation here in Beijing that will lead drug development not only for China but also for other Asian countries," said Kemal Malik, member of the board of management of Bayer Schering Pharma, head of global development and chief medical officer. "Our aim is to systematically include Asian patients earlier in global drug development, breaking the tradition of US and EU first.."
Bayer Schering Pharma is also currently in advanced discussions with Tsinghua University on entering into a unique strategic partnership to pursue research collaborations for the discovery of new disease-related targets in the core areas of Bayer's pharmaceutical research. With this partnership Bayer would be the first multinational company in China to enter into a partnership with such a respected and renowned Chinese university.
"China is home to a large pool of skilled medical and scientific talents. Our goal is to work closely together with our Chinese partners to support China conducting their own r&d activities and at the same time we will be able to strengthen our own r&d capabilities," said Fibig.
